The PMTA Deadline Is Approaching

May 25, 2022 Leave a message

Manufacturers of non-tobacco nicotine (NTN) products on the market as of April 14, 2022 must file a Premarket Tobacco Product Application (PMTA) with the U.S. Food and Drug Administration by May 14, 2022 if they wish to continue selling their products.

The May 14 deadline applies only to applicants who submit electronically, as required by the FDA. However, the applicant may request that FDA waive the submission of PMTA in a different format. The FDA must receive the application in hard copy form by 4 p.m. Eastern Daylight Time on Friday, May 13.

FDA received a 14-day extension from the U.S. District Court for the District of Maryland to file the first PMTA status report required by the court's revised remedy order on April 29.

"The request for an extension is supported by legitimate reasons. The information required to compile the status report requires considerable time and effort, and defendants have been working with plaintiffs to resolve any ambiguity about which applications will be covered by the status report, "the motion notes.

The new law also states that tobacco-derived "prior versions" of NTN products cannot be sold later if they receive negative FDA action against PMTA, such as a denial of filing or marketing denial order. No FDA marketing approval was received on May 14, 2022.

According to the agency, even if a new PMTA is submitted, such products must be withdrawn from the market until a marketing permission order is received. Products marketed after July 13, 2022 that do not have FDA marketing approval are in violation of Section 910 of the Food, Drug, and Cosmetic Act and may be subject to FDA enforcement.

For products not marketed as of April 14, 2022, PMTA must be submitted to the FDA and marketing authorization must be obtained before the product can be marketed in the United States.